Skip to main content Back to Top
Advertisement

3/11/2020

Alcohol Dehydrated Injection (Ethanol)

Products Affected - Description

    • Alcohol Dehydrated (Ethanol) injection, Akorn, 98% or greater, 5 mL vial, 10 count, NDC 17478-0503-05 - discontinued
    • Alcohol Dehydrated (Ethanol) injection, Seton Pharmaceuticals, 98% or greater, 5 mL vial, 10 count, NDC 13925-0177-10 - discontinued

Reason for the Shortage

    • Akorn has stopped manufacturing and distributing dehydrated alcohol as of February 18, 2020.
    • BPI has Ablysinol available. It is the only FDA-approved dehydrated alcohol product.
    • Seton has discontinued dehydrated alcohol.

Available Products

    • Ablysinol injection, BPI Labs, 99% or greater, 5 mL ampule, 10 count, NDC 62250-0105-02

Estimated Resupply Dates

    • Akorn's dehydrated alcohol injection is being distributed by FFF Enterprises. Customers can call FFF Enterprises at 1-800-843-7477 to place orders until supplies are depleted.

Updated

Updated March 11, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 9, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.